Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Sales | 12,000 | 7,616 | 26,071 | 54,896 | 10,548 |
| Cost of Goods | N/A | N/A | 86 | N/A | N/A |
| Gross Profit | 12,000 | 7,616 | 25,985 | 50,352 | 10,548 |
| Operating Expenses | 22,990 | 17,946 | 28,800 | 39,810 | 21,245 |
| Operating Income | -10,990 | -10,330 | -2,729 | 15,086 | -10,697 |
| Other Income | 126 | 137 | 134 | 66 | 70 |
| Pre-tax Income | -10,864 | -10,193 | -2,595 | 15,152 | -10,627 |
| Net Income Continuous | -10,864 | -10,193 | -2,595 | 15,152 | -10,627 |
| Net Income | $-10,864 | $-10,193 | $-2,595 | $15,152 | $-10,627 |
| EPS Basic Total Ops | -0.24 | -0.23 | -0.06 | 0.40 | -0.28 |
| EPS Basic Continuous Ops | -0.24 | -0.23 | -0.06 | 0.40 | -0.28 |
| EPS Diluted Total Ops | -0.24 | -0.23 | -0.06 | 0.40 | -0.28 |
| EPS Diluted Continuous Ops | -0.24 | -0.23 | -0.06 | 0.40 | -0.28 |
| EBITDA(a) | $-10,682 | $-9,932 | $-2,338 | $15,482 | $-10,303 |